Cervical intraepithelial neoplasia and higher long term risk of cancer

British Medical Journal

Volumn 335, Issue 7629, 2007, Pages 1053-1054

  Ronco, Guglielmo ^a   Giovanni, Mario ^b   Ciatto, Stefano ^c  

^a Centre for Cancer Prevention   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c Cancer Research and Prevention Centre   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER RISK; CONSERVATIVE TREATMENT; EDITORIAL; HUMAN; INCIDENCE; MEDICAL LITERATURE; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED KINGDOM; UTERINE CERVIX CARCINOMA IN SITU;

AGE FACTORS; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MASS SCREENING; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 36749000408     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39364.439444.80     Document Type: Editorial

References (11)

1. Soutter WP, Sasieni P, Panoskaltsis T. Long term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia. Int J Cancer 2006;118:2048-55.
2. Strander B, Andersson-Ellström A, Milsom I, Sparén P. Risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study. BMJ 2007 doi: 10.1136/bmj.39363.471806. BE.
3. Soutter WP, De Barras Lopes A, Fletcher A, Monhagan JM, Duncan ID, Paraskevaidis E, et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet 1997;349:978-80.
4. Kalliala I, Anttila A, Pukkala E, Nieminen P. Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study. BMJ 2005;331:303-15.
5. IARC Working Group on the Evaluation of Cancer Preventive Strategies. Cervix cancer screening. IARC handbooks of cancer prevention. No10. Lyon: IARC, 2005.
6. Arbyn M, Paraskevaidis E, Martin-Hirsch P, Prendiville W, Dillner J. Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol Oncol 2005;99:S7-11.
7. Lopes A, Mor-Yosef S, Pearson S, Ireland D, Monhagan JM. Is routine colposcopic assessment necessary following laser ablation of cervical intraepithelial neoplasia? Br J Obstet Gynaecol 1990;97:175-7.
8. Dalla Palma P, Giorgi Rossi P, Collina G, Buccoliero AM, Ghiringhello B, Lestani M, et al. The risk of false-positive histology according to the reason for colposcopy referral in cervical cancer screening: a blind revision of all histological lesions found in the NTCC trial. Am J Clin Pathol (in press).
9. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007;370:890-907.
10. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskievadis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta analysis. Lancet 2006;367:489-98.
11. Wright TC, Cox JT, Massad LS, Carlson DO, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines forthe management of women with intraepithelial neoplasia. Am J Obstet Gynecol 2003;189:295-304.